跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avastin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avastin
Approved
STANDARD
Avastin
Roche Diagnostics GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
404da2f1608d0848
Company
Roche Diagnostics GmbH
Type
Standard
Approval Details
Approval Id
404da2f1608d0848
Drug Approval Philippines Name
Avastin
Product Name
Avastin
Registration Number
BR-739
Brand Name
Avastin
Generic Name
Bevacizumab
Dosage Form
Concentrate for Solution for Infusion (IV)
Dosage Strength
400 mg/16 mL (25 mg/mL)
Manufacturer
Roche Diagnostics GmbH
Trader
F.Hoffman-La Roche Ltd.
Importer
Roche (Philippines) Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/roche-diagnostics-gmbh
Trader Detail Path
/organization/f-hoffman-la-roche-ltd
Issuance Date
25 May 2025
Expiry Date
09 July 2031
Pharmacologic Category
VEGF/VEGFR (Vascular Endothelial Growth Factor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
404da2f1608d0848
Type
Standard
Back to Philippines FDA Approvals